Recently, a " JAK2 " inhibitor, namely ruxolitinib, has been approved for use in primary myelofibrosis.
22.
He died in 2002 from myelofibrosis caused by contact with cobalt-60 while working at the Maralinga nuclear test facility.
23.
One is evaluating the efficacy of glasdegib in treating myelofibrosis in patients who were unable to control the disease with ruxolitinib.
24.
Myelofibrosis can be a late complication of other myeloproliferative disorders, such as polycythemia vera, and less commonly, essential thrombocythaemia.
25.
The Leukemia and Lymphoma Society describes myelofibrosis as a rare type of blood cancer, manifesting as a type of chronic leukemia.
26.
As of 2011, momelotinib is being developed as a drug for myelofibrosis and currently undergoes Phase I / II clinical trials.
27.
This was likely myelofibrosis, a rare bone marrow disease or agnogenic myeloid metaplasia, both of which were incurable at the time.
28.
In 2014 Geron Corporation received permission to resume a trial of its drug imetelstat for myelofibrosis after addressing FDA concerns over liver toxicity.
29.
Hairy cell leukemia was originally described as histiocytic leukemia, malignant reticulosis, or lymphoid myelofibrosis in publications dating back to the 1920s.
30.
Mutations in CALR have been found in the majority of " JAK2 " and MPL-negative essential thrombocythemia and myelofibrosis.
